dr mary claire haver and glp 1 GLP-1 medications were never designed to be a quick fix., In this episode of unPAUSED, Dr. Michelle Gordon (@doctormichellegordon) explains why GLP-1s are intended to treat obesity as the chronic Mary Claire Haver, MD -
Description
The prognostic determinant of interleukin-10 in patients with acute ischemic stroke: an analysis from the perspective of disease management
Accessed July 25, 2023
If you respond well to GLP-1 stimulation alone, semaglutide gets you significant weight loss at a lower price point
GLP-1R agonist promotes proliferation of neuroendocrine neoplasm cells expressing GLP-1 receptors
when they did so, the email bounced back
doi: 10.1016/j.mce.2013.01.009
